Junbo Hu
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 2%
- Bone Metabolism and Diseases
- Extracellular vesicles in disease
Papers in
- Oncology 24
- Cancer-related Molecular Pathways 10
-
- MicroRNA in disease regulation 6
- Co-authors
- Xuelai Luo (45 shared papers)Guihua Wang (38 shared papers)Fuqing Hu (16 shared papers)Jingqin Lan (12 shared papers)Jianping Gong (37 shared papers)Yongdong Feng (22 shared papers)Zhenlin Hou (9 shared papers)Chao Wan (1 shared paper)
- Journals
- Cell Death and Disease (6 papers)Oncotarget (6 papers)Oncogene (6 papers)Scientific Reports (4 papers)Cancer Research (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Junbo Hu
144 papers receiving 6.5k citations
Junbo Hu's Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 480
- Molecular Biology 1.4k
- Oncology 484
- Clinical Psychology 355
- Immunology 284
Countries citing papers authored by Junbo Hu
This map shows the geographic impact of Junbo Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbo Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbo Hu more than expected).
Fields of papers citing papers by Junbo Hu
This network shows the impact of papers produced by Junbo Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbo Hu. The network helps show where Junbo Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junbo Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 147 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TGF-β1–induced migration of bone mesenchymal stem cells couples bone resorption with formation Hit paper breakdown → | 2009 | 1005 |
| 2 | M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer Hit paper breakdown → | 2018 | 541 |
| 3 | Lactate Is a Natural Suppressor of RLR Signaling by Targeting MAVS Hit paper breakdown → | 2019 | 507 |
| 4 | 2020 | 436 | |
| 5 | IL-6 regulates autophagy and chemotherapy resistance by promoting BECN1 phosphorylation Hit paper breakdown → | 2021 | 189 |
| 6 | 2019 | 179 | |
| 7 | 2016 | 173 | |
| 8 | 2019 | 159 | |
| 9 | 2019 | 119 | |
| 10 | 2016 | 90 | |
| 11 | 2014 | 87 | |
| 12 | 2018 | 87 | |
| 13 | 2013 | 78 | |
| 14 | 2010 | 72 | |
| 15 | 2019 | 69 | |
| 16 | 2018 | 67 | |
| 17 | 2016 | 64 | |
| 18 | 2017 | 56 | |
| 19 | 2020 | 56 | |
| 20 | 2023 | 55 |
About Junbo Hu
Junbo Hu is a scholar working on Oncology, Cancer Research, Molecular Biology, Gastroenterology and Reproductive Medicine, having authored 147 papers that have together received 6.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Gastric Cancer Management and Outcomes (8 papers), Cervical Cancer and HPV Research (7 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), MicroRNA in disease regulation (6 papers), Ovarian cancer diagnosis and treatment (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Gastrointestinal Tumor Research and Treatment (5 papers). The work is most often cited by research in Cancer Research (480 citations), Molecular Biology (1.4k citations), Oncology (484 citations), Clinical Psychology (355 citations) and Immunology (284 citations). Junbo Hu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xuelai Luo, Guihua Wang, Fuqing Hu, Jingqin Lan, Jianping Gong, Yongdong Feng, Zhenlin Hou, Chao Wan, Xu Feng and Xu Cao. Their work appears in journals such as Cell Death and Disease, Oncotarget, Oncogene, Scientific Reports and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.